FDA 483 - Rochal Technologies - August 01, 2024

Rochal Technologies, a specification developer in San Antonio, TX, received two observations during an FDA inspection. The firm failed to adequately establish procedures for receiving, reviewing, and evaluating complaints, leading to numerous device reports not being properly documented or evaluated. Additionally, procedures for the rework of nonconforming products were not adequately established, resulting in insufficient documentation of rework activities.